This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Antisense Pharma Gmbh. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovations of Piotr Jachimczak
Introduction
Piotr Jachimczak is a notable inventor based in Wuerzburg, Germany. He has made significant contributions to the field of biomedical research, particularly in the area of cancer treatment. His work focuses on innovative methods to inhibit melanoma, a serious form of skin cancer.
Latest Patents
Jachimczak holds a patent for a "Method for inhibiting 'melanoma inhibitory activity' MIA." This invention is directed towards peptides, antibodies, and antibody fragments that inhibit the activity of Melanoma Inhibitory Activity (MIA). This advancement has the potential to improve therapeutic strategies for melanoma patients.
Career Highlights
Currently, Piotr Jachimczak is associated with Antisense Pharma GmbH, a company dedicated to developing innovative therapies for cancer treatment. His role at the company allows him to apply his expertise in peptide and antibody research to create effective solutions for combating melanoma.
Collaborations
Throughout his career, Jachimczak has collaborated with esteemed colleagues such as Anja-Katrin Bosserhoff and Reinhard Buettner. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic approaches.
Conclusion
Piotr Jachimczak's contributions to the field of cancer research through his innovative patent and collaborations highlight his commitment to improving patient outcomes. His work continues to inspire advancements in the treatment of melanoma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile